Holly Rockweiler is co-founder and CEO of Madorra women’s health company dedicated to changing the treatment paradigm for vaginal atrophy and dryness. She co-founded Madorra as a spin-out of the Stanford Biodesign Fellowship where she implemented ethnographic research to identify unmet clinical needs and define user, market, and product requirements for solutions in women’s health, urology, nephrology, and infectious disease. Prior to Biodesign she worked as a senior research scientist at Boston Scientific where she developed therapies to enable more efficient care for patients living with heart failure. Rockweiler earned her master’s and bachelor’s degrees in biomedical engineering from Washington University in St. Louis.